Third Annual Science2Startup Symposium Will Foster Collaboration Between Researchers, Entrepreneurs and Top Investors
The Herbert Wertheim UF Scripps Institute researcher Kirill Martemyanov selected to present
Science2Startup (S2S)™, an invitation-only symposium presented by Atlas Venture, F-Prime Capital, Osage University Partners, RA Capital Management, 5AM Ventures and Massachusetts Biotechnology Council (MassBio) that aims to strengthen connections between therapeutics researchers at the world’s top academic research institutions and biotech investors, will be held May 3, 2023 at the Broad Institute in Cambridge, Massachusetts. S2S is returning for the first time since 2019, with a focus on bringing academic innovations in the therapeutics space to the attention of the thriving Boston-based venture capital ecosystem.
Ten selected presenters will showcase their discoveries as well as their projected development path toward clinical proof-of-concept. Kirill Martemyanov, Ph.D., professor and chair of The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, is one of the 10 presenters. He will discuss new strategies for improving safety of opioid drugs and combating opioid use disorder based on innovative discovery of novel drug targets.
Read more about Third Annual Science2Startup (S2S)™ Symposium Will Foster Collaboration Between Researchers, Entrepreneurs and Top Investors.Kirill Martemyanov received an Invention of the Year Award in 2022 for his research. His video interview here: https://youtu.be/_6YGyghMAwU